Prostaglandins and the Uterus:
The introduction of prostaglandins into clinical practice has been one of the most important advances in obstetrics and gynaecology in recent years. During the last decade obstetricians have become familiar with these drugs for inducing labour and for terminating second-trimester pregnancy. Within t...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
London
Springer London
1992
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The introduction of prostaglandins into clinical practice has been one of the most important advances in obstetrics and gynaecology in recent years. During the last decade obstetricians have become familiar with these drugs for inducing labour and for terminating second-trimester pregnancy. Within the last year their use has been extended, in association with antiprogestin, to first-trimester termi nation. Although the effectiveness of prostaglandins in these pharma cological roles is clear, their full potential has still to be explored, and much remains to be learned about their physiology. Prostaglandins playa central role in the initiation of labour. Further clarification of this role could lead to improvements in preventing or treating preterm labour, which still remains the most important cause of perinatal mortality in this country. Prostaglandins are also inti mately involved in the mechanism of menstruation. More detailed understanding of this role should lead to more effective treatments for menorrhagia and dysmenorrhoea. These substances also playa part in the mechanism of implantation, and further research in this area may lead to more effective therapy for infertility |
| Beschreibung: | 1 Online-Ressource (XIV, 301 p) |
| ISBN: | 9781447119319 |
| DOI: | 10.1007/978-1-4471-1931-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144709 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1992 |||| o||u| ||||||eng d | ||
| 020 | |a 9781447119319 |9 978-1-4471-1931-9 | ||
| 024 | 7 | |a 10.1007/978-1-4471-1931-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4471-1931-9 | ||
| 035 | |a (OCoLC)1119017655 | ||
| 035 | |a (DE-599)BVBBV046144709 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 618.2 |2 23 | |
| 084 | |a YM 4144 |0 (DE-625)153841:12951 |2 rvk | ||
| 245 | 1 | 0 | |a Prostaglandins and the Uterus |c edited by James O. Drife, Andrew A. Calder |
| 264 | 1 | |a London |b Springer London |c 1992 | |
| 300 | |a 1 Online-Ressource (XIV, 301 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The introduction of prostaglandins into clinical practice has been one of the most important advances in obstetrics and gynaecology in recent years. During the last decade obstetricians have become familiar with these drugs for inducing labour and for terminating second-trimester pregnancy. Within the last year their use has been extended, in association with antiprogestin, to first-trimester termi nation. Although the effectiveness of prostaglandins in these pharma cological roles is clear, their full potential has still to be explored, and much remains to be learned about their physiology. Prostaglandins playa central role in the initiation of labour. Further clarification of this role could lead to improvements in preventing or treating preterm labour, which still remains the most important cause of perinatal mortality in this country. Prostaglandins are also inti mately involved in the mechanism of menstruation. More detailed understanding of this role should lead to more effective treatments for menorrhagia and dysmenorrhoea. These substances also playa part in the mechanism of implantation, and further research in this area may lead to more effective therapy for infertility | ||
| 650 | 4 | |a Obstetrics/Perinatology/Midwifery | |
| 650 | 4 | |a Obstetrics | |
| 650 | 0 | 7 | |a Gebärmutter |0 (DE-588)4019493-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Frühgeburt |0 (DE-588)4155535-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Geburt |0 (DE-588)4019589-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prostaglandine |0 (DE-588)4127390-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zyklusstörung |0 (DE-588)4135702-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schwangerschaftsstörung |0 (DE-588)4180321-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z London |2 gnd-content | |
| 689 | 0 | 0 | |a Frühgeburt |0 (DE-588)4155535-1 |D s |
| 689 | 0 | 1 | |a Prostaglandine |0 (DE-588)4127390-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Geburt |0 (DE-588)4019589-2 |D s |
| 689 | 1 | 1 | |a Prostaglandine |0 (DE-588)4127390-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Schwangerschaftsstörung |0 (DE-588)4180321-8 |D s |
| 689 | 2 | 1 | |a Prostaglandine |0 (DE-588)4127390-4 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Zyklusstörung |0 (DE-588)4135702-4 |D s |
| 689 | 3 | 1 | |a Prostaglandine |0 (DE-588)4127390-4 |D s |
| 689 | 3 | |8 1\p |5 DE-604 | |
| 689 | 4 | 0 | |a Gebärmutter |0 (DE-588)4019493-0 |D s |
| 689 | 4 | 1 | |a Prostaglandine |0 (DE-588)4127390-4 |D s |
| 689 | 4 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Drife, James O. |4 edt | |
| 700 | 1 | |a Calder, Andrew A. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781447119333 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540197195 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781447119326 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4471-1931-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524894 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-1-4471-1931-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180480459800576 |
|---|---|
| any_adam_object | |
| author2 | Drife, James O. Calder, Andrew A. |
| author2_role | edt edt |
| author2_variant | j o d jo jod a a c aa aac |
| author_facet | Drife, James O. Calder, Andrew A. |
| building | Verbundindex |
| bvnumber | BV046144709 |
| classification_rvk | YM 4144 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4471-1931-9 (OCoLC)1119017655 (DE-599)BVBBV046144709 |
| dewey-full | 618.2 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 618 - Gynecology, obstetrics, pediatrics, geriatrics |
| dewey-raw | 618.2 |
| dewey-search | 618.2 |
| dewey-sort | 3618.2 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4471-1931-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04018nmm a2200721zc 4500</leader><controlfield tag="001">BV046144709</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1992 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781447119319</subfield><subfield code="9">978-1-4471-1931-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4471-1931-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4471-1931-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119017655</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144709</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">618.2</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YM 4144</subfield><subfield code="0">(DE-625)153841:12951</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prostaglandins and the Uterus</subfield><subfield code="c">edited by James O. Drife, Andrew A. Calder</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Springer London</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 301 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The introduction of prostaglandins into clinical practice has been one of the most important advances in obstetrics and gynaecology in recent years. During the last decade obstetricians have become familiar with these drugs for inducing labour and for terminating second-trimester pregnancy. Within the last year their use has been extended, in association with antiprogestin, to first-trimester termi nation. Although the effectiveness of prostaglandins in these pharma cological roles is clear, their full potential has still to be explored, and much remains to be learned about their physiology. Prostaglandins playa central role in the initiation of labour. Further clarification of this role could lead to improvements in preventing or treating preterm labour, which still remains the most important cause of perinatal mortality in this country. Prostaglandins are also inti mately involved in the mechanism of menstruation. More detailed understanding of this role should lead to more effective treatments for menorrhagia and dysmenorrhoea. These substances also playa part in the mechanism of implantation, and further research in this area may lead to more effective therapy for infertility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obstetrics/Perinatology/Midwifery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Obstetrics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gebärmutter</subfield><subfield code="0">(DE-588)4019493-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Frühgeburt</subfield><subfield code="0">(DE-588)4155535-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Geburt</subfield><subfield code="0">(DE-588)4019589-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostaglandine</subfield><subfield code="0">(DE-588)4127390-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zyklusstörung</subfield><subfield code="0">(DE-588)4135702-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schwangerschaftsstörung</subfield><subfield code="0">(DE-588)4180321-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">London</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Frühgeburt</subfield><subfield code="0">(DE-588)4155535-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Prostaglandine</subfield><subfield code="0">(DE-588)4127390-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Geburt</subfield><subfield code="0">(DE-588)4019589-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Prostaglandine</subfield><subfield code="0">(DE-588)4127390-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Schwangerschaftsstörung</subfield><subfield code="0">(DE-588)4180321-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Prostaglandine</subfield><subfield code="0">(DE-588)4127390-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Zyklusstörung</subfield><subfield code="0">(DE-588)4135702-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Prostaglandine</subfield><subfield code="0">(DE-588)4127390-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Gebärmutter</subfield><subfield code="0">(DE-588)4019493-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Prostaglandine</subfield><subfield code="0">(DE-588)4127390-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Drife, James O.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calder, Andrew A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781447119333</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540197195</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781447119326</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4471-1931-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524894</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4471-1931-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 London gnd-content |
| genre_facet | Konferenzschrift 1991 London |
| id | DE-604.BV046144709 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:26Z |
| institution | BVB |
| isbn | 9781447119319 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524894 |
| oclc_num | 1119017655 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XIV, 301 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Springer London |
| record_format | marc |
| spelling | Prostaglandins and the Uterus edited by James O. Drife, Andrew A. Calder London Springer London 1992 1 Online-Ressource (XIV, 301 p) txt rdacontent c rdamedia cr rdacarrier The introduction of prostaglandins into clinical practice has been one of the most important advances in obstetrics and gynaecology in recent years. During the last decade obstetricians have become familiar with these drugs for inducing labour and for terminating second-trimester pregnancy. Within the last year their use has been extended, in association with antiprogestin, to first-trimester termi nation. Although the effectiveness of prostaglandins in these pharma cological roles is clear, their full potential has still to be explored, and much remains to be learned about their physiology. Prostaglandins playa central role in the initiation of labour. Further clarification of this role could lead to improvements in preventing or treating preterm labour, which still remains the most important cause of perinatal mortality in this country. Prostaglandins are also inti mately involved in the mechanism of menstruation. More detailed understanding of this role should lead to more effective treatments for menorrhagia and dysmenorrhoea. These substances also playa part in the mechanism of implantation, and further research in this area may lead to more effective therapy for infertility Obstetrics/Perinatology/Midwifery Obstetrics Gebärmutter (DE-588)4019493-0 gnd rswk-swf Frühgeburt (DE-588)4155535-1 gnd rswk-swf Geburt (DE-588)4019589-2 gnd rswk-swf Prostaglandine (DE-588)4127390-4 gnd rswk-swf Zyklusstörung (DE-588)4135702-4 gnd rswk-swf Schwangerschaftsstörung (DE-588)4180321-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 London gnd-content Frühgeburt (DE-588)4155535-1 s Prostaglandine (DE-588)4127390-4 s DE-604 Geburt (DE-588)4019589-2 s Schwangerschaftsstörung (DE-588)4180321-8 s Zyklusstörung (DE-588)4135702-4 s 1\p DE-604 Gebärmutter (DE-588)4019493-0 s 2\p DE-604 Drife, James O. edt Calder, Andrew A. edt Erscheint auch als Druck-Ausgabe 9781447119333 Erscheint auch als Druck-Ausgabe 9783540197195 Erscheint auch als Druck-Ausgabe 9781447119326 https://doi.org/10.1007/978-1-4471-1931-9 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Prostaglandins and the Uterus Obstetrics/Perinatology/Midwifery Obstetrics Gebärmutter (DE-588)4019493-0 gnd Frühgeburt (DE-588)4155535-1 gnd Geburt (DE-588)4019589-2 gnd Prostaglandine (DE-588)4127390-4 gnd Zyklusstörung (DE-588)4135702-4 gnd Schwangerschaftsstörung (DE-588)4180321-8 gnd |
| subject_GND | (DE-588)4019493-0 (DE-588)4155535-1 (DE-588)4019589-2 (DE-588)4127390-4 (DE-588)4135702-4 (DE-588)4180321-8 (DE-588)1071861417 |
| title | Prostaglandins and the Uterus |
| title_auth | Prostaglandins and the Uterus |
| title_exact_search | Prostaglandins and the Uterus |
| title_full | Prostaglandins and the Uterus edited by James O. Drife, Andrew A. Calder |
| title_fullStr | Prostaglandins and the Uterus edited by James O. Drife, Andrew A. Calder |
| title_full_unstemmed | Prostaglandins and the Uterus edited by James O. Drife, Andrew A. Calder |
| title_short | Prostaglandins and the Uterus |
| title_sort | prostaglandins and the uterus |
| topic | Obstetrics/Perinatology/Midwifery Obstetrics Gebärmutter (DE-588)4019493-0 gnd Frühgeburt (DE-588)4155535-1 gnd Geburt (DE-588)4019589-2 gnd Prostaglandine (DE-588)4127390-4 gnd Zyklusstörung (DE-588)4135702-4 gnd Schwangerschaftsstörung (DE-588)4180321-8 gnd |
| topic_facet | Obstetrics/Perinatology/Midwifery Obstetrics Gebärmutter Frühgeburt Geburt Prostaglandine Zyklusstörung Schwangerschaftsstörung Konferenzschrift 1991 London |
| url | https://doi.org/10.1007/978-1-4471-1931-9 |
| work_keys_str_mv | AT drifejameso prostaglandinsandtheuterus AT calderandrewa prostaglandinsandtheuterus |